Saint Antoine Hospital
Paris, 75012, France
NCT Number: NCT04446208
Endoscopic treatment of early post-operative fistula in patients with underlying esophageal or gastric cancer has now become the standard of care. However, data regarding the yield of this type of treatment is lacking. This study aims to evaluate endoscopic management of this post-operative complication. The main outcome of this prospective observational study conducted in tertiary centers in France is fistula healing defined as the absence of collection on CT scan (with opacification) in a patient on PO diet, 3 months after the end of the endoscopic treatment.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Paris, 75012, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Endoscopic treatment will consist in placement of a metal stent in a patient with early fistula (< 15 days) and/or a large fistula orifice, and no abscess, or double pigtail plastic stents if the fistula is older than 15 days and the orifice is small.
Time frame: 3 months after the end of the endoscopic
The main outcome is fistula healing defined as the absence of collection on CT scan (with opacification) in a patient on PO diet, 3 months after the end of the endoscopic treatment.
Looking for future studies?
Notify MeAymeric Becq
Other
Endoscopic Treatment of Post-operative Fistula of the Upper Digestive Tract
Acronym: FISTULENDO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05943119
Fistula, Neoplasms
Caen, France
View Trial DetailsNCT03118986
Hematopoietic System--Cancer, Nausea
San Francisco, California, United States
View Trial DetailsNCT03349450
Adult Diffuse Large Cell Lymphoma, Adult Refractory Diffuse Large B-Cell Lymphoma
Calgary, Alberta, Canada
View Trial DetailsNCT07834021
Neoplasms, Well-Being
Edegem, Antwerp, Belgium
View Trial Details